stanley l. hem - Purdue College of Pharmacy - Purdue University

131. K.J. Hem, E.A. Dandashli, J.L. White and S.L. Hem, “Accessibility of Antigen in Vaccines Produced
by In-Situ Alum Precipitation,” Vaccine Research, 5, 187-191 (1996).
132. M.-F. Chang, J.L. White, S.L. Nail and S.L. Hem, “Role of the Electrostatic Attractive Force in the
Adsorption of Proteins by Aluminum Hydroxide Adjuvant,” PDA Journal of Pharmaceutical Science
and Technology, 51, 1-5 (1997).
133. S.E. Gruenhagen, D.G. Schulze, G. Chansiri, K.J. Hem, J.L. White and S.L. Hem, “Effect of Sorbitol on
the Phosphate Adsorptive Capacity of Ferrihydrite Suspensions,” Pharmaceutical Development and
Technology, 2, 81-86 (1997).
134. R.E. Flarend, S.L. Hem, J.L. White, D. Elmore, M.A. Suckow, A.C. Rudy and E.A. Dandashli, “In-vivo
Absorption of Aluminium-Containing Vaccine Adjuvants Using 26 Al,” Vaccine, 15, 1314-1318 (1997).
135. S.L. Hem, “Industrial Scientists and Engineers: an Underutilized Academic Resource,” Pharm. Dev.
Tech., 2, vii-viii (1997).
136. J.V. Rinella, Jr., R.F. Workman, M.A. Hermodson, J.L. White and S.L. Hem, “Elutability of Proteins
from Aluminum-Containing Vaccine Adjuvants by Treatment with Surfactants,” J. Colloid Interface
Sci., 197, 48-56 (1998).
137. J.V. Rinella, Jr., J.L. White and S.L. Hem, “Effect of pH on the Elution of Model Antigens from
Aluminum-Containing Adjuvants,” J. Colloid Interface Sci., 205, 161-165 (1998).
138. G. Chansiri, R.T. Lyons, M.V. Patel and S.L. Hem, “Effect of Surface Charge on the Stability of O/W
Emulsions During Steam Sterilization,” J. Pharm. Sci., 88, 454-458 (1999).
139. L.S. Burrell, E.B. Lindblad, J.L. White and S.L. Hem, “Stability of Aluminium-Containing Adjuvants
to Autoclaving,” Vaccine, 17, 2599-2603 (1999).
140. J.M. Heimlich, F.E. Regnier, J.L. White and S.L. Hem, “The In-Vitro Displacement of Adsorbed Model
Antigens from Aluminium-Containing Adjuvants by Interstitial Proteins,” Vaccine, 17, 2873-2881
(1999).
141. T. Bin, A.K. Kulshreshtha, R. Al-Shakhshir and S.L. Hem, “Adsorption of Benzalkonium Chloride by
Filter Membranes: Mechanisms and Effects of Formulation and Processing Parameters,” Pharm. Dev.
Tech., 4, 151-165 (1999).
142. R. Flarend, C. Keim, T. Bin, D. Elmore, S. Hem and M. Ladisch, “Analysis of Aluminium –26 Labeled
Aluminum Chlorohydrate,” J. Inorg.Biochem., 76, 149-152 (1999).
143. T. Bin, L. McCrosky, A.K. Kulshreshtha and S.L. Hem, “Adsorption of Esters of p-Hydroxybenzoic
Acid by Filter Membranes: Mechanism and Effect of Formulation and Processing Parameters,” Pharm.
Dev. Tech., 5, 95-104 (2000).
144. J. Klein, M. Ushio, L.S. Burrell, B. Wenslow and S.L. Hem, “Analysis of Aluminum
Hydroxyphosphate Vaccine Adjuvants by 27-Al MAS NMR,” J. Pharm. Sci., 89, 311-321 (2000).
145. L.S. Burrell, J.L. White and S.L. Hem, “Stability of Aluminum–Containing Adjuvants During Aging at
Room Temperature,” Vaccine, 18, 2188-2192 (2000).
146. L.S. Burrell, C.T. Johnston, D. Schulze, J. Klein, J.L. White and S.L. Hem, “Aluminum Phosphate
Adjuvants Precipitated at Constant pH I: Composition and Structure,” Vaccine, 19, 275-281 (2000).
147. L.S. Burrell, C.T. Johnson, D. Schulze, J. Klein, J.L. White and S.L. Hem, “Aluminum Phosphate
Adjuvants Precipitated at Constant pH II: Physicochemical Properties,” Vaccine, 19, 282-287 (2000).
15